US2021008139A1PendingUtilityA1

Cannabis compositions and methods

Assignee: 3277991 NOVA SCOTIA LTD D/B/A/ TRURO HERBAL COPriority: Jul 3, 2016Filed: Sep 8, 2020Published: Jan 14, 2021
Est. expiryJul 3, 2036(~9.9 yrs left)· nominal 20-yr term from priority
A61K 36/3482A61K 31/658A61K 9/4866A61P 23/00A61K 47/44B01D 11/0288A61K 36/185A61K 31/05A61K 31/352
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition comprises an extract from a first Cannabis plant tissue and an extract from a second Cannabis plant tissue.

Claims

exact text as granted — not AI-modified
1 . A composition comprising an extract from a first  Cannabis  plant tissue and an extract from a second  Cannabis  plant tissue. 
     
     
         2 . The composition of  claim 1 , wherein the first and second  Cannabis  plant tissues are of the same species. 
     
     
         3 . The composition of  claim 2 , wherein the first and second  Cannabis  plant tissues are of the same strain. 
     
     
         4 . The composition of  claim 2 , wherein the first and second  Cannabis  plant tissues are of different strains, optionally wherein the first and second  Cannabis  plant tissues are of different species. 
     
     
         5 . (canceled) 
     
     
         6 . The composition of  claim 1 , wherein the first and second  Cannabis  plant tissues are independently selected from fresh and dried, optionally from the group consisting of flowers, leaves, stems, roots, and seeds. 
     
     
         7 . (canceled) 
     
     
         8 . The composition of  claim 1 , wherein the first  Cannabis  plant tissue is flower tissue. 
     
     
         9 . The composition of  claim 8 , wherein the flower tissue is bud tissue. 
     
     
         10 . The composition of  claim 9 , wherein the bud tissue is sinsemilla. 
     
     
         11 . The composition of  claim 6 , wherein the second  Cannabis  plant tissue is leaf tissue, optionally wherein the leaf tissue is trim. 
     
     
         12 . (canceled) 
     
     
         13 . The composition of  claim 1 , further comprising an extract from a third  Cannabis  plant tissue. 
     
     
         14 . The composition of  claim 13 , wherein the third  Cannabis  plant tissue is of the same species or is of the same strain as at least one of the first and the second  Cannabis  plant tissue. 
     
     
         15 . (canceled) 
     
     
         16 . The composition of  claim 13 , wherein the third  Cannabis  plant tissue is of a different species than the first and second  Cannabis  plant tissue. 
     
     
         17 . The composition of  claim 1 , further comprising a diluent. 
     
     
         18 . The composition of  claim 17 , wherein the diluent is an oil or butter, optionally clarified butter, or combination thereof. 
     
     
         19 . (canceled) 
     
     
         20 . The composition of  claim 18 , wherein the diluent is an oil, optionally a plant derived oil. 
     
     
         21 . (canceled) 
     
     
         22 . The composition of  claim 20 , wherein the oil is hemp seed oil or olive oil. 
     
     
         23 . The composition of  claim 1 , further comprising at least one pharmaceutical agent. 
     
     
         24 . The composition of  claim 23 , wherein the pharmaceutical agent is selected from the group consisting of a vitamin (such as vitamin D), an analgesic, a muscle relaxant, and an anti-inflammatory agent. 
     
     
         25 - 30 . (canceled) 
     
     
         31 . The composition of  claim 1 , formulated for enteral delivery, parenteral delivery, injection, inhalation, transdermal delivery, or sublingual delivery. 
     
     
         32 . The composition of  claim 31 , formulated into a tablet or capsule. 
     
     
         33 - 34 . (canceled) 
     
     
         35 . The composition of  claim 1 , wherein the extract from the first and second  Cannabis  plant tissues interact synergistically to treat and/or prevent a disease and/or symptom of a disease. 
     
     
         36 . (canceled) 
     
     
         37 . A method of treating and/or preventing a disease and/or symptom of a disease, the method comprising administering the composition of  claim 1 . 
     
     
         38 . (canceled) 
     
     
         39 . A method of reducing the use of smoked  Cannabis  in a subject, the method comprising administering the composition of  claim 1 .

Join the waitlist — get patent alerts

Track US2021008139A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.